Status:
COMPLETED
Interval Intraocular Pressure in Intravitreal Injection Study
Lead Sponsor:
The University of Hong Kong
Conditions:
Glaucoma
Intraocular Pressure
Eligibility:
All Genders
50+ years
Phase:
NA
Brief Summary
This is a prospective study of IOP in Intravitreal injections to evaluate: 1. IOP effect of intravitreal injection 2. IOP response to prophylactic beta blocker or Prostaglandin vs control (Hypromello...
Detailed Description
Study design: A prospective study Sample size: 60 patients (180 readings) Recruitment: Patients will be recruited at the intravitreal injection clinic in Grantham Hospital. Randomization: Group 1: c...
Eligibility Criteria
Inclusion
- AMD patients requiring multiple intravitreal injections (Eylea or Lucentis), not necessarily 3 month loading.
- Age \>50
- Chinese patients with ability to read Chinese ICF
Exclusion
- Known glaucoma
- Corneal disease e.g. corneal scarring or opacity preventing fundal view
- On steroid or anti glaucoma eye drops
- Prior vitrectomy or glaucoma surgery
- Recent intraocular surgery i.e. cataracts surgery
- Pseudophakic with anterior chamber IOL
- History of ocular inflammatory disease e.g. uveitis
- Previous laser iridotomy
- Recent intravitreal injection of steroid
- Inability for regular follow-up
Key Trial Info
Start Date :
October 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2021
Estimated Enrollment :
64 Patients enrolled
Trial Details
Trial ID
NCT04868175
Start Date
October 1 2019
End Date
April 1 2021
Last Update
April 30 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
HKSDS Program
Hong Kong, Hong Kong, 000000